Proactive Investors - Run By Investors For Investors

Orgenesis CEO says investors realizing building out infrastructure in biotechs is important

Orgenesis (NASDAQ:ORGS) CEO Vered Caplan spoke with Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Caplan participated in the forum's panel entitled "Cell and gene therapy: The financing surge."

 
Meet ICOx Innovations, Zynerba Pharmaceuticals, Pressure BioSciences Inc. and Alchemist Inc at our event, New York , 30 January 2019. Register here »
View full ORGS profile View Profile

Orgenesis Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use